Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr. Bill Releford Finds Continued Success with Platelet Rich Plasma to Treat Chronic Non-Healing Wounds
  • USA - English


News provided by

Releford Foot and Ankle Institute

Jul 14, 2013, 12:00 ET

Share this article

Share toX

Share this article

Share toX

Los Angeles, CA (PRWEB) July 14, 2013 -- Dr. Bill J Releford, DPM, medical director and founder of the Releford Foot and Ankle Institute announced today results from several case studies using platelet rich plasma therapy to heal chronic nonhealing wounds. Each patient was recommended for high level amputation and were not candidates for revascularization or had failed attempts to be revascularized or had comorbidities that were contraindications to revascularization. Each patient was treated with a series of three injections of PRP over a six week period. The most profound initial subjective finding was decreased pain due to ischemia. "After the first failed bypass surgery I was scheduled for another attempt. If that didn’t work, then amputation of my left leg was the last option. The improvement in my leg and wound has been so great that my vascular surgeon has postponed the second bypass," states Robert J., patient at the Releford Foot and Ankle Institute.

"This is a new and exciting application of platelet rich plasma therapy, which is usually used in the sports medicine arena," states Dr. Bill Releford. "P.R.P. is another tool to help decrease the amputation rate among those that are most at risk," Dr. Releford continues.

ABOUT P.R.P.

Platelet Rich Plasma therapy, also known as P.R.P. is a revolutionary way to address tissue injury by using "healing" components derived from a patient’s own blood. These "healing components" or growth factors have been shown to be effective in treating ankle sprains, Achilles Tendonitis, Heel Pain / Plantar Fasciitis, Ischemic Pain as well as Chronic Non-Healing Wounds, as cited in the J ournal of Orthopedic Research (Jan 2006) This therapy has been recently popularized by success experienced by professional athletes such Tiger Woods, Pittsburgh Steelers Hines Ward and Troy Palomalu.

THE PROCESS FOR RECOVERING PLATELETS

A very small amount of blood is drawn from the patient into a sterile tube in the exact same manner as a standard blood sample. The tube containing a patient's blood is placed into a centrifuge and spun to separate the platelets from the other blood components. After a few minutes, the concentrated platelets are removed from the same tube and re-introduced into the patient at the site of the injury. Using a sterile needle, your physician will inject the PRP in and around the injury site. This is all accomplished without using any animal products or other foreign material.

ABOUT DR. BILL JAMES RELEFORD

Dr. BILL J. RELEFORD, D.P.M., a graduate of the Temple School of Podiatric Medicine in Philadelphia, began his practice in 1990 and established the Diabetic Foot Institute, a facility dedicated exclusively to the reduction of diabetes-related amputations in high-risk populations. Dr. Releford is recognized both domestically as well as internationally as a leader in the field of diabetic limb preservation and wound care.

Dr. Bill Releford’s limb salvage and wound care success involves utilizing a multi-disciplinary approach to limb salvage where vascular surgeons, infectious disease specialist, plastic surgeons, endocrinologist all collaborate solely for the benefit of salvaging a foot at risk of amputation. Dr. Releford also uses Platelet Rich Plasma Therapy to treatment foot injuries as well as chronic non-healing wounds.

Dr. Bill Releford is founder and CEO of The Releford Foot & Ankle Institute in Los Angeles. The Releford Institute’s mission is to effectively decrease the diabetes related amputation rate in Los Angeles and its surrounding communities by providing a comprehensive wound care and limb salvage service. The Releford Institute addresses patients specialized needs and creates individual treatment plans to heal wounds and prevent amputations.

Dr. Bill Releford’s community outreach and health care advocacy efforts are facilitated through the Diabetic Amputation Prevention Foundation (DAP), a non profit organization he founded in 2001, whose mission is to increase public awareness of diabetes through culturally specific education and community based programs. The education of at risk populations to better understand the disease, its complications as well as the standard of care as it relates to diabetes is the primary focus.

Dr. Bill Releford and the DAP Foundation have been recognized for the success of the Black Barbershop Health Outreach Program. Since it's inception in December 2007, the program has screened over 25,000 men for diabetes and hypertension in over 450 black owned barbershops in over 26 cities. Dr. Bill Releford is an assistant professor at Charles R. Drew University and lectures both domestically as well as internationally about the latest techniques in limb salvage and community based outreach strategies. Additionally, Dr. Releford has recently authored his much anticipated book, "Five Colors A Day to Better Health." Dr. Releford and his work have been featured on NBC Nightly News with Brian Williams, ABC’s THE VEIW as a featured guest, The Washington Post, Newsweek as well as the Los Angeles Times.

Dr. Bill Releford, Releford Foot and Ankle Institute, http://www.relefordinstitute.com, 310-412-0183, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.